DCM
VERA icon

Driehaus Capital Management’s Vera Therapeutics VERA Stock Holding History

Driehaus Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-106,815
Closed -$4.72M – 456
2024
Q3 		$4.72M Sell
106,815
-148,318
-58% -$5.63M 0.04% 280
2024
Q2 		$9.23M Sell
255,133
-2,124
-0.8% -$84.3K 0.09% 224
2024
Q1 		$11.1M Buy
257,257
+188,951
+277% +$6.73M 0.11% 228
2023
Q4 		$1.05M Hold
68,306
– – 0.01% 313
2023
Q3 		$936K Hold
68,306
– – 0.01% 330
2023
Q2 		$1.1M Buy
+68,306
New +$617K 0.01% 313

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Driehaus Capital Management's VERA Position: Q4 2024 in Review

Driehaus Capital Management sold out of Vera Therapeutics (VERA) in Q4 2024, closing a stake of 106,815 shares — an estimated $4.72M sold.

Driehaus Capital Management first reported a position in VERA in Q2 2023 and held it in 6 quarters. The position peaked at $11.1M in Q1 2024. 178 funds tracked by Wall St. Rank hold VERA as of Q4 2024.

  • Driehaus Capital Management reported no remaining Vera Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 106,815 Vera Therapeutics shares in Q4 2024, an estimated $4.72M.
  • Driehaus Capital Management first reported a position in Vera Therapeutics in Q2 2023 and held it in 6 quarters.
  • Driehaus Capital Management's Vera Therapeutics position peaked at $11.1M in Q1 2024.
  • 178 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2024.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.